Skip to main content
logo
BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan flag Japan · Delayed Price · Currency is JPY
54.00
+1.00 (1.89%)
Aug 27, 2026, 3:30 PM JST

TYO:4594 Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2018FY 2017
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '18 Mar '17
Market Capitalization
7,3619,3243,9334,56533,67723,373
Market Cap Growth
0.43%137.05%-13.84%-86.44%44.09%-
Enterprise Value
5,2058,380-1,301-66929,73519,369
Last Close Price
53.0069.0044.0067.00805.00628.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2018FY 2017
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '18 Mar '17
PS Ratio
87633.75111001.553471.7063409.2795.1344.18
PB Ratio
3.113.944.254.664.854.50
P/TBV Ratio
3.113.944.254.664.864.51

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2018FY 2017
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '18 Mar '17
EV/Sales Ratio
-99758.62--84.0036.62

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2018FY 2017
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '18 Mar '17
Debt / Equity Ratio
--0.030.12--
Net Debt / Equity Ratio
-0.91-0.91-0.85-0.96-0.94-0.95
Net Debt / EBITDA Ratio
---0.824.384.61
Net Debt / FCF Ratio
1.581.580.630.813.844.25
Asset Turnover
000.00-0.06-
Inventory Turnover
----9.16-
Quick Ratio
13.6813.686.655.7328.8431.08
Current Ratio
15.8315.838.146.1830.1332.54
Return on Equity (ROE)
-79.25%-79.25%-120.92%--25.97%-
Return on Assets (ROA)
-43.45%-43.45%-61.73%--15.44%-
Return on Capital Employed (ROCE)
-53.00%-53.00%-117.40%-111.10%-22.30%-21.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2018FY 2017
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '18 Mar '17
Earnings Yield
-17.73%-13.99%-29.27%-25.59%-4.68%-4.76%
FCF Yield
-18.56%-14.66%-31.82%-25.48%-5.04%-4.98%
Buyback Yield / Dilution
-36.87%-36.87%-27.03%-67.81%-12.41%-